2020
06.11.2020
Joint EU-UK pharmaceutical industry response to Specialised Committee outcome
09.10.2020
MHRA guidance on the licensing of biosimilar products
25.03.2020
COVID-19 BGMA update
20.03.2020
Key worker welcome
18.03.2020
Covid-19 statement
10.02.2020
Dr Andrew Ellis Appointed New BBA Chair
06.02.2020
Reaction to the Government’s document on the UK’s approach to trade deals with non-EU nations
Highlights
25.03.2020 COVID-19 BGMA update 20.03.2020 Key worker welcome 18.03.2020 Covid-19 statement 10.02.2020 Dr Andrew Ellis Appointed New BBA Chair 06.02.2020 Reaction to the Government’s document on the UK’s approach to trade deals with non-EU nations 28.11.2019 Trade agreement claims 03.04.2019 British Biosimilars Association (BBA) appoints new vice-chair 23.11.2018 New voluntary scheme for Branded Medicines Pricing and Access 15.10.2018 Adalumimab launches 24.09.2018 FMD safety feature consultation response 24.08.2018 No-deal Brexit technical notices and reference products 23.08.2018 Response to government’s publication of technical notices on plans to regulate medicines in the event of a no-deal Brexit 23.08.2018 Response to the Secretary of State for Health’s letter to medicines Marketing Authorisation Holders 07.08.2018 Reaction to the Government’s publication of a consultation on changes to the statutory medicines pricing scheme 31.07.2018 Director General of the British Generic Manufacturers Association (BGMA) and British Biosimilars Association (BBA) Warwick Smith’s reaction to NHS Improvements study on the savings delivered from 10 medicines which have switched to generics or biosimilars 14.12.2017 BREXIT Life Science Coalition Joint position paper media release 14.12.2017 UK Exiting from EU Life Science industry coalition position paper 27.11.2017 Reaction to the Government’s Industrial Strategy White Paper 15.11.2017 British Biosimilars Association (BBA) appoints new chair 10.10.2017 Response to the publication the Care Quality Commission’s annual State of Care report 12.09.2017 Reaction from the British Biosimilars Association (BBA) to NHS England’s Simon Stevens speech at the Expo conference in Manchester. 31.08.2017 BGMA Statement on Sir John Bell's Life Sciences Industrial Strategy
18.04.2016
British Biosimilars Association (BBA) launches in UK